Oligosymptomatic Kidney Transplant Patients With COVID-19: Do They Pose a Risk to Other Recipients? Transplant Proc 2020 Nov;52(9):2663-2666
Date
05/19/2020Pubmed ID
32419709Pubmed Central ID
PMC7225704DOI
10.1016/j.transproceed.2020.05.028Scopus ID
2-s2.0-85086045174 (requires institutional sign-in at Scopus site) 10 CitationsAbstract
The clinical course of viral infections in patients under immunosuppression can be atypical and/or fatal if not diagnosed and treated appropriately. The coronavirus disease 2019 (COVID-19) may also have an atypical presentation. Contrary to the general opinion, transplant patients may be asymptomatic or oligosymptomatic, which could be a risk factor for underdiagnosis and the dissemination of this viral disease. This study presents the clinical features of 2 oligosymptomatic kidney transplant patients diagnosed with COVID-19. We suggest that new screening algorithms for COVID-19 should be reconsidered for the transplant patient population.
Author List
Kocak B, Arpali E, Akyollu B, Yelken B, Tekin S, Kanbay M, Turkmen A, Kalayoglu MAuthor
Emre Arpali MD, PhD Associate Professor in the Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultBetacoronavirus
Coronavirus Infections
Female
Humans
Immunocompromised Host
Immunosuppressive Agents
Kidney Transplantation
Middle Aged
Pandemics
Pneumonia, Viral
Risk Factors
Transplant Recipients
